首页> 美国卫生研究院文献>Indian Journal of Clinical Biochemistry >Circadian Periodicity of Circulating Plasma Lipid Peroxides Uric Acid and Ascorbic Acid in Renal Stone Formers
【2h】

Circadian Periodicity of Circulating Plasma Lipid Peroxides Uric Acid and Ascorbic Acid in Renal Stone Formers

机译:肾结石形成者中循环血浆脂质过氧化物尿酸和抗坏血酸的昼夜周期性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Circadian periodicity of plasma lipid peroxides and serum ascorbic acid and uric acid levels were studied in one hundred renal stone formers (55 women and 45 men; age 20–60 years) and 50 clinically healthy volunteers (21 women and 29 men; age 21–45 years) with diurnal activity from 06:00 to 22:00 and nocturnal rest. A marked circadian variation was demonstrated by population-mean-cosinor for all studied variables in stone formers and healthy subjects. By comparison to the healthy controls, parameter tests indicate that the stone formers had a higher MESOR (±SE) of MDA (2.90 ± 0.03 vs. 2.28 ± 0.06; F = 94.929, p < 0.001), a lower MESOR of serum ascorbic acid (0.722 ± 0.010 vs. 0.839 ± 0.10; F = 32.083, p < 0.001), and a similar MESOR of serum uric acid. Furthermore, the patients also differed from the healthy subjects in terms of their circadian amplitude and acrophase (tested jointly) of all three variables (p < 0.001). The demonstration herein of a circadian rhythm in MDA, serum ascorbic and uric acid suggests that these variables could also serve as markers to optimize the timing of treatment and to assess the patient’s response to treatment for further management.
机译:在一百名肾结石形成者(55名女性和45名男性;年龄20至60岁)和50名临床健康的志愿者(21名女性和29名男性; 21至21岁)中研究了血浆脂质过氧化物,血清抗坏血酸和尿酸水平的昼夜周期。 45岁),白天活动时间为06:00至22:00,并且有夜间休息。在结石形成者和健康受试者中,所有研究变量的总体均值余弦值显示出明显的昼夜节律变化。与健康对照相比,参数测试表明结石形成者的MDA的MESOR(±SE)较高(2.90±0.03比2.28±0.06; F = 94.929,p <0.001),血清抗坏血酸的MESOR较低(0.722±0.010 vs.0.839±0.10; F = 32.083,p <0.001),和血清尿酸的MESOR相似。此外,患者的所有三个变量的昼夜节律振幅和顶相(共同测试)也与健康受试者不同(p <0.001)。此处显示的MDA,血清抗坏血酸和尿酸的昼夜节律表明,这些变量还可以用作标记,以优化治疗时机并评估患者对治疗的反应以进一步治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号